MiR-182 Modulates Myocardial Hypertrophic Response Induced by Angiogenesis in Heart

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Na ^a   Hwangbo, Cheol ^a   Jaba, Irina M ^a   Zhang, Jiasheng ^a   Papangeli, Irinna ^a   Han, Jinah ^a   Mikush, Nicole ^a   Larrivée, Bruno ^a,c   Eichmann, Anne ^a,b   Chun, Hyung J ^a   Young, Lawrence H ^a   Tirziu, Daniela ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MICRORNA; MIRN182 MICRORNA, MOUSE; MULTIPROTEIN COMPLEX; NITRIC OXIDE; NOS3 PROTEIN, MOUSE; PIGF PROTEIN, MOUSE; PROTEIN; PROTEIN KINASE B; RGS PROTEIN; RGS4 PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CARDIOMEGALY; ENDOTHELIUM; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; UPREGULATION;

ANIMALS; CARDIOMEGALY; ENDOTHELIUM; MICE; MICE, KNOCKOUT; MICRORNAS; MULTIPROTEIN COMPLEXES; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RGS PROTEINS; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84959141477     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21228     Document Type: Article

References (43)

1. Tirziu, D., Giordano, F. J. & Simons, M. Cell communications in the heart. Circulation 122, 928-937 (2010).
2. Izumiya, Y. et al. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47, 887-893 (2006).
3. Shiojima, I. et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115, 2108-2118 (2005).
4. Walsh, K. & Shiojima, I. Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 117, 3176-3179 (2007).
5. Heineke, J. et al. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 117, 3198-3210 (2007).
6. Tomanek, R. J., Doty, M. K. & Sandra, A. Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor. Circ Res 82, 587-593 (1998).
7. Tirziu, D. et al. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 117, 3188-3197 (2007).
8. Roncal, C. et al. Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 216, 236-244 (2008).
9. Bry, M. et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122, 1725-1733 (2010).
10. Accornero, F. et al. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 109, 272-280 (2011).
11. Jaba, I. M. et al. NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth. J Clin Invest 123, 1718-1731 (2013).
12. Kivela, R. et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med 6, 307-321 (2014).
13. Hu, R. G. et al. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature 437, 981-986 (2005).
14. Mittmann, C. et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc Res 55, 778-786 (2002).
15. Dweep, H., Sticht, C., Pandey, P. & Gretz, N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44, 839-847 (2011).
16. Hudson, M. B. et al. miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle. Am J Physiol Cell Physiol 307, C314-C319 (2014).
17. Segura, M. F. et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmiaassociated transcription factor. Proc Natl Acad Sci USA 106, 1814-1819 (2009).
18. Yang, W.-B. et al. Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget 5, 740-753, (2014).
19. Saus, E. et al. Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia. Hum Mol Genet 19, 4017-4025 (2010).
20. Xu, S., Witmer, P. D., Lumayag, S., Kovacs, B. & Valle, D. MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. J Biol Chem 282, 25053-25066 (2007).
21. Autiero, M. et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9, 936-943 (2003).
22. Ahmad, S. et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 99, 715-722 (2006).
23. Wei, L. et al. Differential expression of microRNAs during allograft rejection. Am J Transplant 12, 1113-1123 (2012).
24. Taurino, C. et al. Gene expression profiling in whole blood of patients with coronary artery disease. Clin Sci (Lond) 119, 335-343 (2010).
25. Cakmak, H. A. et al. The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study. J Cardiovasc Med (Hagerstown, Md) 16, 431-437 (2015).
26. Guttilla, I. K. & White, B. A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284, 23204-23216 (2009).
27. Skurk, C. et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 280, 20814-20823 (2005).
28. Wang, K. et al. Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a. J Biol Chem 287, 589-599 (2012).
29. Young, L. H. et al. Myocardial protein turnover in patients with coronary artery disease. Effect of branched chain amino acid infusion. J Clin Invest 87, 554-560 (1991).
30. Shimizu, N. et al. Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal Muscle. Cell Metabolism 13, 170-182 (2011).
31. She, P. et al. Disruption of BCATm in Mice Leads to Increased Energy Expenditure Associated with the Activation of a Futile Protein Turnover Cycle. Cell Metabolism 6, 181-194 (2007).
32. Blomstrand, E., Eliasson, J., Karlsson, H. K. R. & Köhnke, R. Branched-Chain Amino Acids Activate Key Enzymes in Protein Synthesis after Physical Exercise. J Nutri 136, 269S-273S (2006).
33. Sancak, Y. et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290-303 (2010).
34. Tato, I., Bartrons, R., Ventura, F. & Rosa, J. L. Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J Biol Chem 286, 6128-6142 (2011).
35. Espinasse, I. et al. Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+ )-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+ )-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure. Cardiovasc Res 42, 87-98 (1999).
36. Sugano, Y. et al. Activated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart. Biochem Biophys Res Commun 405, 349-355 (2011).
37. Perrino, C. et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116, 1547-1560 (2006).
38. Pereira, R. O. et al. Maintaining PGC-1alpha expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function. FASEB J 28, 3691-3702 (2014).
39. Arany, Z. et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1a . Nature 451, 1008-1012 (2008).
40. Du, C. et al. Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. J Exp Clin Cancer Res 34, 67 (2015).
41. Hu, P. et al. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285, H1261-1269 (2003).
42. Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30, 207-210 (2002).
43. Tirziu, D. et al. Endothelial nuclear factor-kappaB-dependent regulation of arteriogenesis and branching. Circulation 126, 2589-2600 (2012).